These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38390676)

  • 1. Challenging Disability Discrimination in the Clinical Use of PDMP Algorithms.
    Pendo E; Oliva J
    Hastings Cent Rep; 2024 Jan; 54(1):3-7. PubMed ID: 38390676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study.
    Freeman PR; Curran GM; Drummond KL; Martin BC; Teeter BS; Bradley K; Schoenberg N; Edlund MJ
    Res Social Adm Pharm; 2019 Jun; 15(6):754-760. PubMed ID: 30243575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health.
    Ali MM; Dowd WN; Classen T; Mutter R; Novak SP
    Addict Behav; 2017 Jun; 69():65-77. PubMed ID: 28152391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical decision making involving prescription drug monitoring programs: A factorial, vignette-based study among student pharmacists.
    Tata V; Varisco TJ; Du N; Nguyen J; Haghparast P; Thornton JD
    J Am Pharm Assoc (2003); 2021; 61(3):316-324. PubMed ID: 33579594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
    Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
    Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription drug monitoring programs operational characteristics and fatal heroin poisoning.
    Martins SS; Ponicki W; Smith N; Rivera-Aguirre A; Davis CS; Fink DS; Castillo-Carniglia A; Henry SG; Marshall BDL; Gruenewald P; Cerdá M
    Int J Drug Policy; 2019 Dec; 74():174-180. PubMed ID: 31627159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.
    Irvine JM; Hallvik SE; Hildebran C; Marino M; Beran T; Deyo RA
    J Pain; 2014 Jul; 15(7):747-55. PubMed ID: 24787089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstate data sharing of prescription drug monitoring programs and associated opioid prescriptions among patients with non-cancer chronic pain.
    Lin HC; Wang Z; Simoni-Wastila L; Boyd C; Buu A
    Prev Med; 2019 Jan; 118():59-65. PubMed ID: 30316875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Have Almost Fifty Years Of Disability Civil Rights Laws Achieved Equitable Care?
    Iezzoni LI; McKee MM; Meade MA; Morris MA; Pendo E
    Health Aff (Millwood); 2022 Oct; 41(10):1371-1378. PubMed ID: 36190880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of state prescription drug monitoring programs: a state-by-state survey.
    Manasco AT; Griggs C; Leeds R; Langlois BK; Breaud AH; Mitchell PM; Weiner SG
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):847-51. PubMed ID: 27061342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research to support optimization of prescription drug monitoring programs.
    Doyle S; Leichtling G; Hildebran C; Reilly C
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1425-1427. PubMed ID: 28905438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment.
    Norwood CW; Wright ER
    Res Social Adm Pharm; 2016; 12(2):257-66. PubMed ID: 26143489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?
    Smith RJ; Kilaru AS; Perrone J; Paciotti B; Barg FK; Gadsden SM; Meisel ZF
    Pain Med; 2015 Jun; 16(6):1122-31. PubMed ID: 25688454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription drug monitoring program design and function: A qualitative analysis.
    Rutkow L; Smith KC; Lai AY; Vernick JS; Davis CS; Alexander GC
    Drug Alcohol Depend; 2017 Nov; 180():395-400. PubMed ID: 28978492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and facilitators to PDMP IS Success in the US: A systematic review.
    Martin HD; Modi SS; Feldman SS
    Drug Alcohol Depend; 2021 Feb; 219():108460. PubMed ID: 33387937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
    Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
    Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012.
    Perrone J; DeRoos FJ; Nelson LS
    J Med Toxicol; 2012 Dec; 8(4):341-52. PubMed ID: 22895794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone related deaths compared to all prescription related deaths.
    Lev R; Petro S; Lee A; Lee O; Lucas J; Castillo EM; Egnatios J; Vilke GM
    Forensic Sci Int; 2015 Dec; 257():347-352. PubMed ID: 26513639
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.